Plasma beta-thromboglobulin: differentiation between intravascular and extravascular platelet destruction.
To elucidate the usefulness of beta-thromboglobulin (beta TG) in the differentiation of the mechanism of thrombocytopenia, plasma beta TG concentration was measured in one patient with amegakaryocytic thrombocytopenia, four patients with autoimmune thrombocytopenia (ATP), two patients with thrombotic thrombocytopenia (TTP), and one patient with thrombocytopenia secondary to disseminated intravascular coagulation (DIC). Plasma beta TG was not measurable in amegakaryocytic thrombocytopenia, was normal in ATP, and was increased in TTP and DIC. These data indicate that in thrombocytopenic patients, increased plasma beta TG concentration may result from intravascular platelet consumption with release of platelet constituents in contrast to extravascular platelet destruction by the macrophage-monocyte system.
D000328:Adult; D000368:Aged; D001327:Autoimmune Diseases / Q000097:blood; D001609:Beta-Globulins; D001792:Blood Platelets / Q000503:physiopathology*; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000150:complications; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017713:Platelet Transfusion; D011697:Purpura, Thrombotic Thrombocytopenic / Q000097:blood; D013921:Thrombocytopenia / Q000097:blood / Q000150:complications; D001620:beta-Thromboglobulin
D001609:Beta-Globulins; D001620:beta-Thromboglobulin